Immunosuppressive Therapy for Chronic Liver Disease

Overview

Journal J R Coll Physicians Lond

Specialty General Medicine

Date 1973 Oct 1

PMID 4583701

Citations 2

Authors

I M Murray-Lyon

Affiliations

Soon will be listed here.

Citing Articles

Cyclosporine-A Versus Prednisolone for Induction of Remission in Auto-immune Hepatitis: Interim Analysis Report of a Randomized Controlled Trial.

Nasseri-Moghaddam S, Nikfam S, Karimian S, Khashayar P, Malekzadeh R Middle East J Dig Dis. 2014; 5(4):193-200.

PMID: 24829691 PMC: 3990153.

Active chronic hepatitis: Part 2.

McCann V Ulster Med J. 1976; 45(2):195-204.

PMID: 188217 PMC: 2385578.

References

COWLING D, Mackay I, TAFT L . Lupoid hepatitis. Lancet. 1956; 271(6957):1323-6. DOI: 10.1016/s0140-6736(56)91483-0. View

DAMESHEK W, Schwartz R . Treatment of certain "autoimmune" diseases with antimetabolites; a preliminary report. Trans Assoc Am Physicians. 1960; 73:113-27. View

Lemmel E, Hurd E, ZIFF M . Differential effects of 6-mercaptopurine and cyclophosphamide on autoimmune phenomena in NZB mice. Clin Exp Immunol. 1971; 8(2):355-62. PMC: 1712938. View

Starzl T, Halgrimson C, Penn I, Martineau G, SCHROTER G, Amemiya H . Cyclophosphamide and human organ transplantation. Lancet. 1971; 2(7715):70-4. PMC: 2790039. DOI: 10.1016/s0140-6736(71)92046-0. View

Lewis G, Jusko W, Graves L, BURKE C . Prednisone side-effects and serum-protein levels. A collaborative study. Lancet. 1971; 2(7728):778-80. DOI: 10.1016/s0140-6736(71)92738-3. View

Miller J, Smith M, Mitchell C, REED W, Eddleston A, Williams R . Cell-mediated immunity to a human liver-specific antigen in patients with active chronic hepatitis and primary biliary cirrhosis. Lancet. 1972; 2(7772):296-7. DOI: 10.1016/s0140-6736(72)92904-2. View

Mackay I . Chronic hepatitis: effect of prolonged suppressive treatment and comparison of azathioprine with prednisolone. Q J Med. 1968; 37(147):379-92. View

Mitchell C, Eddleston A, Smith M, Williams R . Serum immunosuppressive activity due to azathioprine and its relation to hepatic function after liver transplantation. Lancet. 1970; 1(7658):1196-9. DOI: 10.1016/s0140-6736(70)91786-1. View

Denman E, DENMAN A, Greenwood B, Gall D, Heath R . Failure of cytotoxic drugs to suppress immune responses of patients with rheumatoid arthritis. Ann Rheum Dis. 1970; 29(3):220-31. PMC: 1031255. DOI: 10.1136/ard.29.3.220. View

10.

Soloway R, Summerskill W, BAGGENSTOSS A, GEALL M, Gitnick G, Elveback I . Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. Gastroenterology. 1972; 63(5):820-33. View

11.

Bach J, Dardenne M . Serum immunosuppressive activity of azathioprine in normal subjects and patients with liver diseases. Proc R Soc Med. 1972; 65(3):260-3. PMC: 1644005. View

12.

BROWN P, GLYNN L, HOLBOROW E . The dual necessity for delayed hypersensitivity and circulating antibody in the pathogenesis of experimental allergic orchitis in guinea-pigs. Immunology. 1967; 13(3):307-14. PMC: 1409356. View

13.

Makinodan T, SANTOS G, Quinn R . Immunosuppressive drugs. Pharmacol Rev. 1970; 22(2):189-247. View

14.

Cook G, Mulligan R, Sherlock S . Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. Q J Med. 1971; 40(158):159-85. DOI: 10.1093/oxfordjournals.qjmed.a067264. View

15.

Smith M, Golding P, Eddleston A, Mitchell C, Kemp A, Williams R . Cell-mediated immune responses in chronic liver diseases. Br Med J. 1972; 1(5799):527-30. PMC: 1787446. DOI: 10.1136/bmj.1.5799.527. View

16.

Doniach D, Roitt I, Walker J, Sherlock S . Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications. Clin Exp Immunol. 1966; 1(3):237-62. PMC: 1579190. View

17.

PHLIPPEN R, Schumacher K, Gross R, Eder M . [Comparative studies on conventional and immunosuppressive therapy of chronic hepatitis using chlorambucil]. Klin Wochenschr. 1969; 47(10):524-32. DOI: 10.1007/BF01715816. View

18.

MacLennan I, LOEWI G, Howard A . A human serum immunoglobulin with specificity for certain homologous target cells, which induces target cell damage by normal human lymphocytes. Immunology. 1969; 17(6):897-910. PMC: 1456030. View

19.

Novack S, Pearson C . Cyclophosphamide therapy in Wegener's granulomatosis. N Engl J Med. 1971; 284(17):938-42. DOI: 10.1056/NEJM197104292841703. View

20.

Paterson P, Drobish D . Cyclophosphamide: effect on experimental allergic encephalomyelitis in Lewis rats. Science. 1969; 165(3889):191-2. DOI: 10.1126/science.165.3889.191. View